Burney Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.45M Sell
113,752
-284,340
-71% -$6.13M 0.08% 202
2025
Q1
$6.61M Buy
398,092
+19,189
+5% +$319K 0.24% 93
2024
Q4
$6.95M Buy
+378,903
New +$6.95M 0.25% 89